Association of MRI Visible Perivascular Spaces and Neurofilament Light Chain: The Framingham Heart Study
Journal of Alzheimer’s Disease · 2023
DOI: 10.3233/jad-221260 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2023. Verfasst von Oluchi Ekenze und 11 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Medical Sciences, Boston University School of Medicine, Boston, MA, USA. Hauptthemen laut MEDLINE: Intermediate Filaments, Cerebral Small Vessel Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIA NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Background
Neurofilament light chain (NfL) is a marker of neuronal injury. Perivascular spaces (PVS) visible on magnetic resonance imaging (MRI) represent cerebral small vessel disease (CSVD) but their role as markers of neuronal injury needs further clarification.
Objective
To relate PVS burden according to brain topography and plasma NfL.
Methods
Framingham Heart Study (FHS) participants with brain MRI and NfL measurements were included. PVS were rated in the basal ganglia (BG) and centrum semiovale (CSO) using validated methods and categorized based on counts. A mixed region variable representing high burden PVS in either BG or CSO was assessed. Multivariable linear regression analyses were used to relate PVS burden to log-transformed NfL levels in models adjusted for age, sex, FHS cohort, time between MRI and clinic exam, and image view (model 1), vascular risk factors (model 2), and white matter hyperintensity volume, covert brain infarcts, and cerebral microbleeds (model 3).
Results
Among 1,457 participants (68.1±8.5 years, 45% males), NfL levels increased with higher PVS burden. Multivariable analysis showed an association of high PVS burden strictly in BG with NfL (β= 0.117, 95% CI 0.014–0.221; p = 0.027), but attenuated in model 3. The associations were mainly in participants≥65 years (β= 0.122, 95% CI 0.015–0.229, p = 0.026), women (β= 0.156, 95% CI 0.024–0.288, p = 0.021), and APOE ɛ4 non-carriers (β= 0.140, 95% CI 0.017–0.263, p = 0.026).
Conclusions
The association of strictly BG high PVS burden with NfL suggests a role for PVS as markers of neuroaxonal injury, but our results are hypothesis generating and require further replication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate Medical Sciences, Boston University School of Medicine, Boston, MA, USA.
- NHLBI's Framingham Heart Study, Framingham, MA, USA.
- Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
- Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
- The Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Sciences Center, San Antonio, TX, USA.
- Department of Population Health Sciences, UT Health San Antonio, San Antonio, TX, USA.
Förderung
- NINDS NIH HHS
- NIA NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Ekenze, O., Pinheiro, A., Demissie, S., Aparicio, H. J., Charidimou, A., Beiser, A. S., Satizabal, C. L., Kautz, T., DeCarli, C., Greenberg, S., Seshadri, S., & Romero, J. R. (2023). Association of MRI Visible Perivascular Spaces and Neurofilament Light Chain: The Framingham Heart Study. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-221260
Vancouver
Ekenze O, Pinheiro A, Demissie S, Aparicio HJ, Charidimou A, Beiser AS, et al. Association of MRI Visible Perivascular Spaces and Neurofilament Light Chain: The Framingham Heart Study. Journal of Alzheimer’s Disease. 2023. doi:10.3233/jad-221260
BibTeX
@article{Ekenze2023,
author = {Ekenze, Oluchi and Pinheiro, Adlin and Demissie, Serkalem and Aparicio, Hugo J and Charidimou, Andreas and Beiser, Alexa S and Satizabal, Claudia L and Kautz, Tiffany and DeCarli, Charles and Greenberg, Steven and Seshadri, Sudha and Romero, Jose R},
title = {Association of MRI Visible Perivascular Spaces and Neurofilament Light Chain: The Framingham Heart Study},
journal = {Journal of Alzheimer’s Disease},
year = {2023},
doi = {10.3233/jad-221260}
}
EUVIMED